Human Amniotic Mesenchymal Stem Cells Inhibit aGVHD by Regulating Balance of Treg and T Effector Cells

References

• Ghimire S, Weber D, Mavin E, Wang XN, Dickinson AM, Holler E. Pathophysiology of GvHD and other HSCT-related major complications. Front Immunol. 2017;8:79. doi:10.3389/fimmu.2017.00079
   PubMed Web of Science ®Google Scholar
• Blazar BR, Murphy WJ, Abedi M. Advances in graft-versus-host disease biology and therapy. Nat Rev Immunol. 2012;12(6):443–458. doi:10.1038/nri3212
   PubMed Web of Science ®Google Scholar
• Wolf D, von Lilienfeld-toal M, Wolf AM, et al. Novel treatment concepts for graft-versus-host disease. Blood. 2012;119(1):16–25. doi:10.1182/blood-2011-08-339465
   PubMed Web of Science ®Google Scholar
• Wu X, Jiang J, Gu Z, Zhang J, Chen Y, Liu X. Mesenchymal stromal cell therapies: immunomodulatory properties and clinical progress. Stem Cell Res Ther. 2020;11(1):345. doi:10.1186/s13287-020-01855-9
   PubMed Web of Science ®Google Scholar
• Malard F, Huang XJ, Sim JPY. Treatment and unmet needs in steroid-refractory acute graft-versus-host disease. Leukemia. 2020;34(5):1229–1240. doi:10.1038/s41375-020-0804-2
   PubMed Web of Science ®Google Scholar
• Deeg HJ. How I treat refractory acute GVHD. Blood. 2007;109(10):4119–4126. doi:10.1182/blood-2006-12-041889
   PubMed Web of Science ®Google Scholar
• Tan Y, Xiao H, Wu D, et al. Combining therapeutic antibodies using basiliximab and etanercept for severe steroid-refractory acute graft-versus-host disease: a Multi-Center Prospective Study. Oncoimmunology. 2017;6(3):e1277307. doi:10.1080/2162402X.2016.1277307
   PubMed Web of Science ®Google Scholar
• Spaggiari GM, Capobianco A, Abdelrazik H, Becchetti F, Mingari MC, Moretta L. Mesenchymal stem cells inhibit natural killer-cell proliferation, cytotoxicity, and cytokine production: role of indoleamine 2,3-dioxygenase and prostaglandin E2. Blood. 2008;111(3):1327–1333. doi:10.1182/blood-2007-02-074997
   PubMed Web of Science ®Google Scholar
• Dazzi F, Lopes L, Weng L. Mesenchymal stromal cells: a key player in ‘innate tolerance? Immunology. 2012;137(3):206–213. doi:10.1111/j.1365-2567.2012.03621.x
   PubMed Web of Science ®Google Scholar
• Ben-Ami E, Berrih-Aknin S, Miller A. Mesenchymal stem cells as an immunomodulatory therapeutic strategy for autoimmune diseases. Autoimmun Rev. 2011;10(7):410–415. doi:10.1016/j.autrev.2011.01.005
   PubMed Web of Science ®Google Scholar
• Pittenger MF, Mackay AM, Beck SC, et al. Multilineage potential of adult human mesenchymal stem cells. Science. 1999;284(5411):143–147. doi:10.1126/science.284.5411.143
   PubMed Web of Science ®Google Scholar
• Rao MS, Mattson MP. Stem cells and aging: expanding the possibilities. Mech Ageing Dev. 2001;122(7):713–734. doi:10.1016/S0047-6374(01)00224-X
   PubMed Web of Science ®Google Scholar
• Lee JM, Jung J, Lee HJ, et al. Comparison of immunomodulatory effects of placenta mesenchymal stem cells with bone marrow and adipose mesenchymal stem cells. Int Immunopharmacol. 2012;13(2):219–224. doi:10.1016/j.intimp.2012.03.024
   PubMed Web of Science ®Google Scholar
• Kagia A, Tzetis M, Kanavakis E, et al. Therapeutic effects of mesenchymal stem cells derived from bone marrow, umbilical cord blood, and pluripotent stem cells in a mouse model of chemically induced inflammatory bowel disease. Inflammation. 2019;42(5):1730–1740. doi:10.1007/s10753-019-01033-x
   PubMed Web of Science ®Google Scholar
• Sharma RR, Pollock K, Hubel A, McKenna D. Mesenchymal stem or stromal cells: a review of clinical applications and manufacturing practices. Transfusion. 2014;54(5):1418–1437. doi:10.1111/trf.12421
   PubMed Web of Science ®Google Scholar
• Antoniadou E, David AL. Placental stem cells. Best Pract Res Clin Obstet Gynaecol. 2016;31:13–29.
   PubMed Web of Science ®Google Scholar
• Insausti CL, Blanquer M, García-Hernández AM, Castellanos G, Moraleda JM. Amniotic membrane-derived stem cells: immunomodulatory properties and potential clinical application. Stem Cells Cloning. 2014;7:53–63.
   PubMedGoogle Scholar
• Ono M, Ohnishi S, Honda M, et al. Effects of human amnion-derived mesenchymal stromal cell transplantation in rats with radiation proctitis. Cytotherapy. 2015;17(11):1545–1559. doi:10.1016/j.jcyt.2015.07.003
   PubMed Web of Science ®Google Scholar
• Liu QW, Huang QM, Wu HY, et al. Characteristics and therapeutic potential of human amnion-derived stem cells. Int J Mol Sci. 2021;22(2):970. doi:10.3390/ijms22020970
   PubMed Web of Science ®Google Scholar
• Li J, Zhou Z, Wen J, Jiang F, Xia Y. Human amniotic mesenchymal stem cells promote endogenous bone regeneration. Front Endocrinol (Lausanne). 2020;11:543623. doi:10.3389/fendo.2020.543623
   PubMed Web of Science ®Google Scholar
• Hong JQ, Gao Y, Song J, Zhuo WB, Sun HT, Ping BH. Comparison of biological characteristics and immunosuppressive activity between human amniotic mesenchymal stem cells and human bone marrow mesenchymal stem cells. Zhongguo Shi Yan Xue Ye Xue Za Zhi. 2016;24(3):858–864.
   PubMedGoogle Scholar
• Song J, Gao Y, Zhou WB, Yang CY, Xu Y, Ping BH. Immunomodulatory effects of human amniotic versus bone marrow-derived mesenchymal stem cells on peripheral blood T lymphocytes in vitro. Nan Fang Yi Ke Da Xue Xue Bao. 2017;37(6):780–785.
   PubMedGoogle Scholar
• Yamahara K, Harada K, Ohshima M, et al. Comparison of angiogenic, cytoprotective, and immunosuppressive properties of human amnion- and chorion-derived mesenchymal stem cells. PLoS One. 2014;9(2):e88319. doi:10.1371/journal.pone.0088319
   PubMed Web of Science ®Google Scholar
• Sun H, Hou Z, Yang H, et al. Multiple systemic transplantations of human amniotic mesenchymal stem cells exert therapeutic effects in an ALS mouse model. Cell Tissue Res. 2014;357(3):571–582. doi:10.1007/s00441-014-1903-z
   PubMed Web of Science ®Google Scholar
• Pianta S, Bonassi Signoroni P, Muradore I, et al. Amniotic membrane mesenchymal cells-derived factors skew T cell polarization toward Treg and downregulate Th1 and Th17 cells subsets. Stem Cell Rev Rep. 2015;11(3):394–407. doi:10.1007/s12015-014-9558-4
   PubMed Web of Science ®Google Scholar
• Yamahara K, Hamada A, Soma T, et al. Safety and efficacy of amnion-derived mesenchymal stem cells (AM01) in patients with steroid-refractory acute graft-versus-host disease after allogeneic haematopoietic stem cell transplantation: a study protocol for a phase I/II Japanese trial. BMJ Open. 2019;9(7):e026403. doi:10.1136/bmjopen-2018-026403
   PubMed Web of Science ®Google Scholar
• Schroeder MA, DiPersio JF. Mouse models of graft-versus-host disease: advances and limitations. Dis Model Mech. 2011;4(3):318–333. doi:10.1242/dmm.006668
   PubMed Web of Science ®Google Scholar
• Lucas PJ, Shearer GM, Neudorf S, Gress RE. The human antimurine xenogeneic cytotoxic response. I. Dependence on responder antigen-presenting cells. J Immunol. 1990;144(12):4548–4554.
   PubMed Web of Science ®Google Scholar
• Ito R, Takahashi T, Katano I, Ito M. Current advances in humanized mouse models. Cell Mol Immunol. 2012;9(3):208–214. doi:10.1038/cmi.2012.2
   PubMed Web of Science ®Google Scholar
• Cooke KR, Kobzik L, Martin TR, et al. An experimental model of idiopathic pneumonia syndrome after bone marrow transplantation: I. The roles of minor H antigens and endotoxin. Blood. 1996;88(8):3230–3239. doi:10.1182/blood.V88.8.3230.bloodjournal8883230
   PubMed Web of Science ®Google Scholar
• Godoy JAP, Paiva RMA, Souza AM, Kondo AT, Kutner JM, Okamoto OK. Clinical translation of mesenchymal stromal cell therapy for graft versus host disease. Front Cell Dev Biol. 2019;7:255. doi:10.3389/fcell.2019.00255
   PubMed Web of Science ®Google Scholar
• Lim JE, Son Y. Endogenous stem cells in homeostasis and aging. Tissue Eng Regen Med. 2017;14(6):679–698. doi:10.1007/s13770-017-0097-3
   PubMed Web of Science ®Google Scholar
• Knuth CA, Kiernan CH, Palomares Cabeza V, Lehmann J, Witte-Bouma J, Ten Berge D. Isolating pediatric mesenchymal stem cells with enhanced expansion and differentiation capabilities. Tissue Eng Part C Methods. 2018;24(6):313–321. doi:10.1089/ten.tec.2018.0031
   PubMed Web of Science ®Google Scholar
• Umezawa A, Hasegawa A, Inoue M, et al. Amnion-derived cells as a reliable resource for next-generation regenerative medicine. Placenta. 2019;84:50–56. doi:10.1016/j.placenta.2019.06.381
   PubMed Web of Science ®Google Scholar
• Evangelista M, Soncini M, Parolini O. Placenta-derived stem cells: new hope for cell therapy? Cytotechnology. 2008;58(1):33–42. doi:10.1007/s10616-008-9162-z
   PubMed Web of Science ®Google Scholar
• Di Nicola M, Carlo-Stella C, Magni M, et al. Human bone marrow stromal cells suppress T-lymphocyte proliferation induced by cellular or nonspecific mitogenic stimuli. Blood. 2002;99(10):3838–3843. doi:10.1182/blood.V99.10.3838
   PubMed Web of Science ®Google Scholar
• Blanco B, Herrero-Sánchez MD, Rodríguez-Serrano C, et al. Immunomodulatory effects of bone marrow versus adipose tissue-derived mesenchymal stromal cells on NK cells: implications in the transplantation setting. Eur J Haematol. 2016;97(6):528–537. doi:10.1111/ejh.12765
   PubMed Web of Science ®Google Scholar
• Huang Y, Yin Y, Gu Y, et al. Characterization and immunogenicity of bone marrow-derived mesenchymal stem cells under osteoporotic conditions. Sci China Life Sci. 2020;63(3):429–442. doi:10.1007/s11427-019-1555-9
   PubMed Web of Science ®Google Scholar
• Keith MC, Bolli R. “String theory” of c-kit(pos) cardiac cells: a new paradigm regarding the nature of these cells that may reconcile apparently discrepant results. Circ Res. 2015;116(7):1216–1230. doi:10.1161/CIRCRESAHA.116.305557
   PubMed Web of Science ®Google Scholar
• Eseonu OI, De Bari C. Homing of mesenchymal stem cells: mechanistic or stochastic? Implications for targeted delivery in arthritis. Rheumatology (Oxford). 2015;54(2):210–218. doi:10.1093/rheumatology/keu377
   PubMed Web of Science ®Google Scholar
• Nitzsche F, Müller C, Lukomska B, Jolkkonen J, Deten A, Boltze J. Concise review: MSC adhesion cascade-insights into homing and transendothelial migration. Stem Cells. 2017;35(6):1446–1460. doi:10.1002/stem.2614
   PubMed Web of Science ®Google Scholar
• Thompson M, Mei SHJ, Wolfe D, et al. Cell therapy with intravascular administration of mesenchymal stromal cells continues to appear safe: an updated systematic review and meta-analysis. E Clin Med. 2020;19:100249.
   Google Scholar
• King MA, Covassin L, Brehm MA, Racki W, Pearson T, Leif J. Human peripheral blood leucocyte non-obese diabetic-severe combined immunodeficiency interleukin-2 receptor gamma chain gene mouse model of xenogeneic graft-versus-host-like disease and the role of host major histocompatibility complex. Clin Exp Immunol. 2009;157(1):104–118. doi:10.1111/j.1365-2249.2009.03933.x
   PubMed Web of Science ®Google Scholar
• King M, Pearson T, Shultz LD, Leif J, Bottino R, Trucco M. A new Hu-PBL model for the study of human islet alloreactivity based on NOD-scid mice bearing a targeted mutation in the IL-2 receptor gamma chain gene. Clin Immunol. 2008;126(3):303–314. doi:10.1016/j.clim.2007.11.001
   PubMed Web of Science ®Google Scholar
• Thangavelu G, Blazar BR. Achievement of tolerance induction to prevent acute graft-vs.-host disease. Front Immunol. 2019;10:309. doi:10.3389/fimmu.2019.00309
   PubMed Web of Science ®Google Scholar
• Tobin LM, Healy ME, English K, Mahon BP. Human mesenchymal stem cells suppress donor CD4(+) T cell proliferation and reduce pathology in a humanized mouse model of acute graft-versus-host disease. Clin Exp Immunol. 2013;172(2):333–348. doi:10.1111/cei.12056
   PubMed Web of Science ®Google Scholar
• Amorin B, Alegretti AP, Valim V, et al. Mesenchymal stem cell therapy and acute graft-versus-host disease: a review. Hum Cell. 2014;27(4):137–150. doi:10.1007/s13577-014-0095-x
   PubMed Web of Science ®Google Scholar
• Tago Y, Kobayashi C, Ogura M, et al. Human amnion-derived mesenchymal stem cells attenuate xenogeneic graft-versus-host disease by preventing T cell activation and proliferation. Sci Rep. 2021;11(1):2406. doi:10.1038/s41598-021-81916-y
   PubMed Web of Science ®Google Scholar
• Cahill EF, Tobin LM, Carty F, Mahon BP, English K. Jagged-1 is required for the expansion of CD4+ CD25+ FoxP3+ regulatory T cells and tolerogenic dendritic cells by murine mesenchymal stromal cells. Stem Cell Res Ther. 2015;6(1):19. doi:10.1186/s13287-015-0021-5
   PubMedGoogle Scholar
• Melief SM, Schrama E, Brugman MH, et al. Multipotent stromal cells induce human regulatory T cells through a novel pathway involving skewing of monocytes toward anti-inflammatory macrophages. Stem Cells. 2013;31(9):1980–1991. doi:10.1002/stem.1432
   PubMed Web of Science ®Google Scholar
• Koreth J, Ritz J. Tregs, HSCT, and acute GVHD: up close and personal. Blood. 2013;122(10):1690–1691. doi:10.1182/blood-2013-07-514125
   PubMed Web of Science ®Google Scholar
• Dong W, Wu X, Ma S, et al. The mechanism of anti-PD-L1 antibody efficacy against PD-L1-negative tumors identifies NK cells expressing PD-L1 as a cytolytic effector. Cancer Discov. 2019;9(10):1422–1437. doi:10.1158/2159-8290.CD-18-1259
   PubMed Web of Science ®Google Scholar
• Bruner RJ, Farag SS. Monoclonal antibodies for the prevention and treatment of graft-versus-host disease. Semin Oncol. 2003;30(4):509–519. doi:10.1016/S0093-7754(03)00250-1
   PubMed Web of Science ®Google Scholar
• Choi SW, Reddy P. Current and emerging strategies for the prevention of graft-versus-host disease. Nat Rev Clin Oncol. 2014;11(9):536–547. doi:10.1038/nrclinonc.2014.102
   PubMed Web of Science ®Google Scholar
• Ng J, Hynes K, White G, et al. Immunomodulatory properties of induced pluripotent stem cell-derived mesenchymal cells. J Cell Biochem. 2016;117(12):2844–2853. doi:10.1002/jcb.25596
   PubMed Web of Science ®Google Scholar
• El-Sherbiny YM, El-Jawhari JJ, Moseley TA, McGonagle D, Jones E. T cell immunomodulation by clinically used allogeneic human cancellous bone fragments: a potential novel immunotherapy tool. Sci Rep. 2018;8(1):13535. doi:10.1038/s41598-018-31979-1
   PubMedGoogle Scholar
• Steinman L. A brief history of TH17, the first major revision in the TH1/TH2 hypothesis of T cell–mediated tissue damage. Nat Med. 2007;13(2):139–145. doi:10.1038/nm1551
   PubMed Web of Science ®Google Scholar
• Cheung TS, Bertolino GM, Giacomini C, Bornhäuser M, Dazzi F, Galleu A. Mesenchymal stromal cells for graft versus host disease: mechanism-based biomarkers. Front Immunol. 2020;11:1338. doi:10.3389/fimmu.2020.01338
   PubMed Web of Science ®Google Scholar
• Kim KW, Moon SJ, Park MJ, et al. Optimization of adipose tissue-derived mesenchymal stem cells by rapamycin in a murine model of acute graft-versus-host disease. Stem Cell Res Ther. 2015;6(1):202. doi:10.1186/s13287-015-0197-8
   PubMedGoogle Scholar
• Gartlan KH, Markey KA, Varelias A, Bunting MD, Koyama M, Kuns RD. Tc17 cells are a proinflammatory, plastic lineage of pathogenic CD8+ T cells that induce GVHD without antileukemic effects. Blood. 2015;126(13):1609–1620. doi:10.1182/blood-2015-01-622662
   PubMed Web of Science ®Google Scholar
• Esplugues E, Huber S, Gagliani N, et al. Control of TH17 cells occurs in the small intestine. Nature. 2011;475(7357):514–518. doi:10.1038/nature10228
   PubMed Web of Science ®Google Scholar
• Capitini CM, Herby S, Milliron M, Anver MR, Mackall CL, Fry TJ. Bone marrow deficient in IFN-{gamma} signaling selectively reverses GVHD-associated immunosuppression and enhances a tumor-specific GVT effect. Blood. 2009;113(20):5002–5009. doi:10.1182/blood-2008-11-187385
   PubMed Web of Science ®Google Scholar
• Merli P, Caruana I, De Vito R, et al. Role of interferon-γ in immune-mediated graft failure after allogeneic hematopoietic stem cell transplantation. Haematologica. 2019;104(11):2314–2323. doi:10.3324/haematol.2019.216101
   PubMed Web of Science ®Google Scholar
• Alvarado LJ, Huntsman HD, Cheng H, et al. Eltrombopag maintains human hematopoietic stem and progenitor cells under inflammatory conditions mediated by IFN-γ. Blood. 2019;133(19):2043–2055. doi:10.1182/blood-2018-11-884486
   PubMed Web of Science ®Google Scholar
• Aggarwal S, Pittenger MF. Human mesenchymal stem cells modulate allogeneic immune cell responses. Blood. 2005;105(4):1815–1822. doi:10.1182/blood-2004-04-1559
   PubMed Web of Science ®Google Scholar